Friday, October 30, 2026

Sirius XM Holdings Already 6% Up, Almost Three Hours Before The NASDAQ Open

Sirius XM Holdings Already 6% Up, Almost Three Hours Before The NASDAQ Open

(VIANEWS) - The NASDAQ opens in less than three hours and Sirius XM Holdings's pre-market value is already 6.8% up.

Sirius XM Holdings's last close was $3.53, 48.47% below its 52-week high of $6.85.

The last session, NASDAQ ended with Sirius XM Holdings (SIRI) rising 1.15% to $3.53. NASDAQ jumped 2.19% to $12,975.69, after two sequential sessions in a row of gains, on what was an all-around up trend trading session.

About Sirius XM Holdings

Sirius XM Holdings Inc., an audio entertainment company, operates audio business including subscription entertainment services in the United States. It operates through Sirius XM, and Pandora and Off-platform segment. The company's Sirius XM segment provides music, sports, entertainment, comedy, news, traffic and weather channels, and other content, as well as podcast and infotainment services on subscription fee basis; and live, curated, and exclusive and on demand programming services through satellite radio system and streamed via applications for mobile and home devices, and other consumer electronic equipment. Its Pandora and Off-platform segment operates music and podcast streaming platform, which offers personalized experience for listener through computers, tablets, mobile devices, vehicle speakers, and connected devices. In addition, the company offers podcasts including true crime to politics, sports, comedy, and other podcasts under Stitcher brand. Further, it distributes satellite radios through automakers and retailers, as well as its website. The company also provides location-based services through two-way wireless connectivity, including safety, security, convenience, remote vehicles diagnostic, maintenance and data, and stolen or parked vehicle locator services. Additionally, it offers satellite television services, which offer music channels on the DISH Network satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; and real-time traffic and weather services, as well as music programming and commercial-free music services for commercial, office, restaurants, and other business. The company was incorporated in 2013 and is headquartered in New York. Sirius XM Holdings Inc. is a subsidiary of Liberty Media Corporation.

Earnings Per Share

As for profitability, Sirius XM Holdings has a trailing twelve months EPS of $0.29.

PE Ratio

Sirius XM Holdings has a trailing twelve months price to earnings ratio of 12.17. Meaning, the purchaser of the share is investing $12.17 for every dollar of annual earnings.

More news about Sirius XM Holdings (SIRI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,503 source documents archived
Query this data → isubstrate.com